SEC Comment Letter 0000000000-23-004391 to PHINIA INC. (PHIN)
PHINIA INC.
Date: April 28, 2023 · CIK: 0001968915 · Accession: 0000000000-23-004391
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
April 28, 2023
Brady Ericson
President and Chief Executive Officer
PHINIA Inc.
3000 University Drive
Auburn Hills, Michigan 48326
Re:PHINIA Inc.
Draft Registration Statement on Form 10
Submitted April 3, 2023
CIK No. 0001968915
Dear Brady Ericson:
We have reviewed your filing and have the following comments. In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response and any amendment you may file in response to these
comments, we may have additional comments.
Draft Registration Statement on Form 10 submitted April 3, 2023
Questions and Answers about the Spin-Off, page iv
1.Please revise your Q&A to discuss the material consequences to stockholders if Borg
Warner waives any conditions and proceeds with the spin-off.
2.Please revise your Q&A to address any material changes in stockholder rights between the
existing BorgWarner common stock and your common stock. If none, please include an
affirmative statement to that effect.
Cautionary Statements for Forward-Looking Information, page 32
3.Please note that the safe harbor for forward-looking statements provided by the Private
Securities Litigation Reform Act of 1995 applies to issuers that are subject to the reporting
requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 at
FirstName LastNameBrady Ericson
Comapany NamePHINIA Inc.
April 28, 2023 Page 2
FirstName LastNameBrady Ericson
PHINIA Inc.
April 28, 2023
Page 2
the time the statements are made. Please revise to remove the implication that the
statements made in your registration statement are within the protection of the Private
Securities Litigation Reform Act of 1995.
Reasons for the Spin-Off, page 34
4.Please revise your disclosure to discuss the potential benefits and negative factors with
equal prominence. In this regard, we note that currently you provide a separate bullet
point for each of the potential benefits, but you include the negative effects in the first full
paragraph on page 35.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations, page 61
5.We note throughout your discussion and analysis of the results of operations for 2022 vs.
2021 starting on page 61 that you attribute the changes in each financial statement line
item to numerous causal factors. Please revise your MD&A to provide a more detailed
and granular discussion that would provide greater transparency into the material
components and potential variability of your selling, general, and administrative expenses
(SG&A), research and development expenses (R&D), and other income (expense). For
example, you should identify each financial statement line item and where you have
multiple components your disclosures should:
•identify and quantify each individually significant component of SG&A and R&D;
•quantify the change in each respective component during each period; and
•discuss the reasons for the increases or decreases in the specific dollar amounts for
each of the components identified.
Liquidity and Capital Resources, page 66
6.You disclose on page F-26 that you have arrangements with various financial institutions
to sell eligible trade receivables from certain customers. If material, please expand your
liquidity and capital resource disclosure to discuss the impact of your factoring
arrangements on your liquidity position during each reported period and disclose any
related known risks and trends.
Management, page 76
7.Please describe the extent and nature of the role of the board of directors in overseeing
cybersecurity risks, including in connection with the company's supply chain,
suppliers/service providers.
Material U.S. Federal Income Tax Consequences of the Spin-Off, page 114
8.We note the statement in the letter to shareholders that the transaction "is intended to"
qualify as a tax-free spin-off. Please revise this section to provide disclosure explaining
the facts or circumstances resulting in this uncertainty and the degree of uncertainty.
FirstName LastNameBrady Ericson
Comapany NamePHINIA Inc.
April 28, 2023 Page 3
FirstName LastName
Brady Ericson
PHINIA Inc.
April 28, 2023
Page 3
9.We note that it is a condition to the spin-off that BorgWarner receive a tax opinion that the
spin-off will qualify as a tax-free reorganization. Please revise this section to disclose
whether this condition can be waived and, if so, how you will notify shareholders of the
waiver of this condition.
Combined Statement of Operations, page F-5
10.We note your line item selling, general and administrative expenses which includes
research and development costs. Tell us your consideration for reflecting research and
development costs separately on the face of your statement of operations given that
it represents a significant portion of your SG&A expenses as well as the emphasis of R&D
activities in your document.
Note 1 - Summary of Significant Accounting Policies
Joint ventures and equity securities, page F-12
11.We note your disclosure that you have a 52.5% non-controlling interest in Delphi-TVS
Diesel Systems Ltd. Please explain and expand your disclosure to provide the basis for
applying the equity method to this investment. Include the significant terms of your
arrangement with reference to the applicable accounting guidance and the reasons why
you believe you do not have a controlling financial interest in it.
General
12.Please file all of your exhibits that are to be filed by amendment as soon as practicable.
We will need adequate time to review and, if necessary, comment upon your disclosure
regarding them.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
You may contact SiSi Cheng at 202-551-5004 or Melissa Gilmore at 202-551-3777 if
you have questions regarding comments on the financial statements and related matters. Please
contact Thomas Jones at 202-551-3602 or Jay Ingram at 202-551-3397 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Patrick G. Quick